Home › Castration-Resistant Prostatic Cancer › New York › Queens
Castration-Resistant Prostatic Cancer clinical trials in Queens, NY
4 studies for Castration-Resistant Prostatic Cancer are looking for participants at sites in and around Queens (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 3
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi away
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
RecruitingPhase 3
- NYU Langone Hospital Long Island, Mineola · 11 mi away
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
RecruitingPhase 1
- Northwell Health R.J. Zuckerberg Cancer Hospital, Lake Success · 9 mi away
- NYU Langone Health Long Island, Mineola · 11 mi away
A Study of MGC026 in Participants With Advanced Solid Tumors
RecruitingPhase 1
- START-New York Long Island, Lake Success · 9 mi away
Castration-Resistant Prostatic Cancer trials in other cities
- Los Angeles, CA8 studies
- New York City, NY7 studies
- Seattle, WA6 studies
- Houston, TX6 studies
- Boston, MA5 studies
- Philadelphia, PA4 studies
- Pittsburgh, PA4 studies
- Mountain View, CA3 studies
- San Francisco, CA3 studies
- Minneapolis, MN3 studies
- Baltimore, MD3 studies
- St. Louis, MO3 studies
Other studies in Queens
- Breast Cancer63 studies
- Non-Small Cell Lung Cancer49 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Ovarian Cancer28 studies
- Prostate Cancer27 studies
- Cancer (all types)26 studies
- Endometrial Cancer25 studies
- Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Head and Neck Squamous Cell Carcinoma20 studies
- Multiple Myeloma20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.